Mediastinal seminomas are rare neoplasms that can be found incidentally in asymptomatic patients. However, a few cases may present in the emergency room with mild to severe respiratory and/or cardiovascular symptoms. This can occur when the tumor grows large enough to cause compression and obstruction of the various structures present in the thorax. Here we present a case of a large medium mediastinal seminoma that grew to the extent of causing pulmonary artery compression which led to chronic passive backflow through the hepatic veins and hepatic congestion. This case was remarkable as well for the presence of testicular microlithiasis, a rare feature with unknown significance to date.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121193PMC
http://dx.doi.org/10.7759/cureus.14527DOI Listing

Publication Analysis

Top Keywords

mediastinal seminoma
8
testicular microlithiasis
8
case primary
4
primary mediastinal
4
seminoma associated
4
associated testicular
4
microlithiasis liver
4
liver injury
4
injury mediastinal
4
mediastinal seminomas
4

Similar Publications

Background: Testicular seminoma is the most common malignant tumor of the testis. It occurs at a rate of 5 per 100 000 men, primarily between the ages of 15 to 34. While seminomas typically occur in the testis, other primary sites include the mediastinum, the retroperitoneum, or other extra-gonadal sites.

View Article and Find Full Text PDF

[A case of synchronous mediastinal and pineal germ cell tumors].

Zhonghua Er Ke Za Zhi

January 2025

Department of Medical Oncology, Pediatric Oncology Center,Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, National Key Clinical Discipline of Pediatric Oncology,Laboratory for Clinical Medicine, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing100045, China.

View Article and Find Full Text PDF

Seminoma is a malignant germ cell tumor that primarily develops in the testis but can occur in other extragonadal areas, most commonly the mediastinum and retroperitoneum. While generally offering a favorable prognosis, seminomas can sometimes clinically present with misleading characteristics resulting in delayed diagnosis. In this article, we report the case of a 31-year-old male diagnosed with grade IIIC intermediate risk testicular seminoma cTxN3M1bSx, who presented initially with a palpable cervical mass.

View Article and Find Full Text PDF

The treatment of patients affected by a teratoma with somatic-type malignancy (STM) is challenging, since they are characterized by a poor prognosis, due to chemoresistance to standard cisplatin-based regimens. Only five more case reports were described for melanomatous STM and for which there are no data available for efficacy evidences of immune checkpoint inhibitors in this setting. Here we report the case of a patient with an initial diagnosis of mediastinal pure seminoma at the first biopsy.

View Article and Find Full Text PDF

Optimal Treatment Strategies for Early-Stage Primary Mediastinal Germ Cell Tumors.

Ann Thorac Surg

November 2024

Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

Article Synopsis
  • The study examines survival outcomes for patients with early-stage primary mediastinal germ cell tumors, comparing surgery and chemotherapy treatment options.
  • Among seminomas, no significant survival difference was found between patients receiving chemotherapy alone and those undergoing surgery; however, for non-seminomatous tumors, surgery showed improved 5-year survival rates.
  • The findings suggest that for non-seminomatous germ cell tumors, a combination of surgery and other treatments leads to better survival compared to chemotherapy alone, while seminomas can achieve similar outcomes with chemotherapy alone.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!